ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cerfolio, R. J.
Right arrow Articles by Pairolero, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cerfolio, R. J.
Right arrow Articles by Pairolero, P. C.

The Annals of Thoracic Surgery, Vol 57, 339-344, Copyright © 1994 by The Society of Thoracic Surgeons


ARTICLES

Pulmonary resection of metastatic renal cell carcinoma

RJ Cerfolio, MS Allen, C Deschamps, RC Daly, SL Wallrichs, VF Trastek and PC Pairolero
Section of General Thoracic Surgery, Mayo Clinic, Rochester, MN 55905.

Between 1965 and 1989, 96 consecutive patients (64 men and 32 women) underwent complete pulmonary resection for metastatic renal cell carcinoma. Median age was 63 years (range, 33 to 82 years). Median time between nephrectomy and pulmonary resection was 3.4 years (range, 0 to 18.4 years). Forty-eight patients had solitary metastasis, 16 had two, 18 had three, and 14 had more than three. Wedge excision was performed in 62 patients, segmentectomy in 3, lobectomy in 25, bilobectomy in 3, and pneumonectomy in 3. Fourteen patients had repeat thoracotomy for recurrent metastasis; 34 other patients also had complete resection of limited extrapulmonary disease. There were no operative deaths. Median follow-up was 3 years (range, 70 days to 19.0 years). Overall 5-year survival was 35.9%. Patients with solitary metastasis had a 5-year survival of 45.6% compared with 27.0% for patients with multiple metastases (p < 0.05). Patients with a tumor-free interval greater than the median of 3.4 years had a better survival (p = 0.05) than those with a tumor-free interval less than or equal to 3.4 years. Five-year survival for patients who underwent repeat thoracotomy or had complete resection of extrapulmonary disease did not differ from overall survival. We conclude that resection of renal lung metastasis is safe and effective, that patients with solitary metastasis have a better survival than those with multiple metastases, that resectable extrapulmonary disease does not necessarily contra-indicate pulmonary resection, and that repeat thoracotomy is warranted in selected patients with recurrent lung metastases.


This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Assouad, E. Banu, E. Brian, D.-N.-M. Pham, A. Dujon, C. Foucault, and M. Riquet
Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer
Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 794 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Cerfolio and A. S. Bryant
Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 261 - 268.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Assouad, B. Petkova, P. Berna, A. Dujon, C. Foucault, and M. Riquet
Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors
Ann. Thorac. Surg., October 1, 2007; 84(4): 1114 - 1120.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. Veronesi, F. Petrella, F. Leo, P. Solli, P. Maissoneuve, D. Galetta, R. Gasparri, G. Pelosi, T. De Pas, and L. Spaggiari
Prognostic role of lymph node involvement in lung metastasectomy
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 967 - 972.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. J. Poncelet, A. Lurquin, B. Weynand, Y. Humblet, P. Noirhomme, and on behalf of the 'Groupe d' Oncologie Thoracique D
Prognostic factors for long-term survival in patients with thoracic metastatic disease: a 10-year experience
Eur. J. Cardiothorac. Surg., February 1, 2007; 31(2): 173 - 180.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. M. Clavero, C. Deschamps, S. D. Cassivi, M. S. Allen, F. C. Nichols III, B. A. Barrette, D. R. Larson, and P. C. Pairolero
Gynecologic Cancers: Factors Affecting Survival After Pulmonary Metastasectomy
Ann. Thorac. Surg., June 1, 2006; 81(6): 2004 - 2007.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. C. Murthy, K. Kim, T. W. Rice, J. Rajeswaran, R. Bukowski, M. M. DeCamp, and E. H. Blackstone
Can We Predict Long-Term Survival After Pulmonary Metastasectomy for Renal Cell Carcinoma?
Ann. Thorac. Surg., March 1, 2005; 79(3): 996 - 1003.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
E. J. Chae, J. K. Kim, S. H. Kim, S.-J. Bae, and K.-S. Cho
Renal Cell Carcinoma: Analysis of Postoperative Recurrence Patterns
Radiology, January 1, 2005; 234(1): 189 - 196.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Ercan, F. C. Nichols III, V. F. Trastek, C. Deschamps, M. S. Allen, D. L. Miller, C. D. Schleck, and P. C. Pairolero
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma
Ann. Thorac. Surg., May 1, 2004; 77(5): 1786 - 1791.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S. Shiono, J. Yoshida, M. Nishimura, J. Nitadori, G. Ishii, Y. Nishiwaki, and K. Nagai
Late Pulmonary Metastasis of Renal Cell Carcinoma Resected 25 Years after Nephrectomy
Jpn. J. Clin. Oncol., January 1, 2004; 34(1): 46 - 49.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Pfannschmidt, H. Hoffmann, T. Muley, S. Krysa, C. Trainer, and H. Dienemann
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
Ann. Thorac. Surg., November 1, 2002; 74(5): 1653 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Piltz, G. Meimarakis, M. W. Wichmann, R. Hatz, F. W. Schildberg, and H. Fuerst
Long-term results after pulmonary resection of renal cell carcinoma metastases
Ann. Thorac. Surg., April 1, 2002; 73(4): 1082 - 1087.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Massard, X. Ducrocq, M. Beaufigeau, S. Elia, R. Kessler, J.-F. Herve, and J.-M. Wihlm
Lung cancer following previous extrapulmonary malignancy
Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 524 - 528.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. B. Zwischenberger and S. K. Alpard
Pulmonary metastasectomy
Ann. Thorac. Surg., July 1, 1999; 68(1): 287 - 288.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Takanami, M. Naruke, and S. Kodaira
LONG-TERM SURVIVAL AFTER RESECTION OF A MEDIASTINAL METASTASIS FROM A RENAL CELL CARCINOMA
J. Thorac. Cardiovasc. Surg., May 1, 1998; 115(5): 1218 - 1219.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. S. Allen and P. C. Pairolero
Inadequacy, Mortality, and Thoracoscopy
Ann. Thorac. Surg., January 1, 1995; 59(1): 6 - 6.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.